{"database": "lobbying", "table": "lobbying_activities", "rows": [[3338465, "b13b32b1-17b5-45e6-90c6-4bb0f3a9d96c", "Q1", "FORBES-TATE", 400976792, "CSL BEHRING", 2025, "first_quarter", "MED", "Issues related to biopharmaceutical pricing; Issues related to plasma and plasma derived therapies; Issues related to the Preserving Life-saving Access to Specialty Medicines in America Act.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2025-04-16T18:59:29-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3338465"], "units": {}, "query_ms": 0.18704100511968136, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}